[1]游建雄,王精兵,艾松涛,等.微球联合碘油栓塞治疗肝癌的近期疗效分析 [J].介入放射学杂志,2017,(06):531-534.
 YOU Jianxiong,WANG Jingbing,AI Songtao,et al.TACE by using microspheres and lipiodol for the treatment of hepatocellular carcinoma: analysis of short- term efficacy[J].journal interventional radiology,2017,(06):531-534.
点击复制

微球联合碘油栓塞治疗肝癌的近期疗效分析


()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年06期
页码:
531-534
栏目:
肿瘤介入
出版日期:
2017-06-25

文章信息/Info

Title:
TACE by using microspheres and lipiodol for the treatment of hepatocellular carcinoma: analysis of short- term efficacy
作者:
游建雄 王精兵 艾松涛 范新东 郑连洲 苏立新 温明哲 杨西涛
Author(s):
YOU Jianxiong WANG Jingbing AI Songtao FAN Xindong ZHEN Lianzhou SU Lixin WEN Minzhe YANG Xitao
Department of Interventional Radiology, Affiliated Ninth People’s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201999, China
关键词:
【关键词】 微球 碘化油 经导管动脉化疗栓塞术 肝细胞癌 介入放射学
文献标志码:
A
摘要:
【摘要】 目的 评价微球联合碘油栓塞肝细胞癌(HCC)的近期疗效及安全性。方法 87例病理证实的肝细胞癌患者随机分为两组,微球组,采用粒径100~300 μm的Embosphere微球联合碘化油栓塞;对照组,采用粒径350~560 μm明胶海绵颗粒联合碘化油栓塞。术后观察生化及影像学变化,分析临床疗效与不良反应。结果 共87例患者行TACE治疗,微球组44例,对照组43例,治疗后微球组疾病获益率与AFP下降较对照组更明显(P<0.05),肝功能指标与术前比较差异无统计学意义(P>0.05),6个月的随访期间微球组介入治疗平均次数少于对照组(P<0.05)。两组患者6、12和18个月生存率差异无统计学意义(P>0.05)。结论 微球联合碘化油栓塞HCC安全,较明胶海绵联合碘化油栓塞近期疗效更明显,能减少患者治疗次数,栓塞前应注意肝动脉门静脉瘘的预处理及微导管的超选。

参考文献/References:

[1] Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53: 1020- 1022.
[2] 朱国庆, 虞希祥, 肖池金, 等. Embosphere微球联合碘油肝动脉栓塞治疗原发性肝癌破裂大出血25例疗效分析[J]. 介入放射学杂志, 2014, 23: 156- 158.
[3] 邵海波, 张曦彤, 李 红, 等. 栓塞微球在肝癌介入治疗中的应用[J]. 介入放射学杂志, 2008, 17: 776- 778.
[4] 姚雪松, 李 槐. 不可手术切除的肝细胞癌的疗效评价标准——改良RECIST标准更可靠[J]. 介入放射学杂志, 2012, 21: 177- 179.
[5] Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients[J]. Gastroenterology, 2006, 131: 461- 469.
[6] Loffroy R, Guiu B, Cercueil JP, et al. Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues[J]. Curr Vasc Pharmacol, 2009, 7: 250- 263.
[7] 陈红栓, 白旭明, 程 龙, 等. 栓塞微球联合碘化油化疗栓塞治疗肝癌的临床研究[J]. 实用医学影像杂志, 2012, 13: 266- 269.
[8] Spreafico C, Cascella T, Facciorusso A, et al. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical- radiological outcomes and safety profile[J]. Cardiovasc Intervent Radiol, 2015, 38: 129- 134.
[9] Deipolyi AR, Oklu R, Al- Ansari S, et al. Safety and efficacy of 70-150 μm and 100-300 μm drug- eluting bead transarterial chemoembolization for hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2015, 26: 516- 522.

相似文献/References:

[1]李伟雄,裴云,李荣富,等.肝脏海绵状血管瘤的介入治疗 附32例报告[J].介入放射学杂志,1997,(01):24.
[2]吴纪瑞,杨永岩,杨熙章,等.丝裂霉素C微囊肝动脉化疗栓塞术治疗中晚期肝癌[J].介入放射学杂志,1992,(01):41.
[3]高德,王建华.经导管动脉内化疗及栓塞治疗骨肉瘤二例[J].介入放射学杂志,1996,(02):87.
[4]王希锐,姜旭,廖顺明,等.泛影葡胺引起急性肾功衰竭致死亡一例[J].介入放射学杂志,1996,(03):129.
[5]张大海,顾伟中,叶强.肝细胞癌的非手术治疗[J].介入放射学杂志,2000,(02):122.
[6]钱 亭,陈茂振,高 峰,等.经肝动脉碘化油/无水乙醇混合剂栓塞消融术治疗兔VX2肝癌的实验研究[J].介入放射学杂志,2014,(08):706.
 QIAN Ting,CHEN Mao zhen,GAO Feng,et al.Transhepatic arterial embolization ablation therapy with Lipiodol ethanol mixture for the treatment of VX2 liver cancer in experimental rabbits[J].journal interventional radiology,2014,(06):706.
[7]史 博,杨东强,郝晓光,等.海藻酸钠微球与碘化油栓塞治疗兔VX2肝转移瘤对比研究[J].介入放射学杂志,2016,(10):896.
 SHI Bo,YANG Dong- qiang,HAO Xiao- guang,et al.Embolization treatment with sodium alginate microspheres or with lipiodol for VX2 liver tumor in experimental rabbits: a comparative study[J].journal interventional radiology,2016,(06):896.
[8]樊 敏,徐 浩,祖茂衡,等.CalliSpheres 载药微球与碘化油栓塞治疗肝转移瘤的近期疗效与安全性对比分析[J].介入放射学杂志,2020,29(12):1253.
 FAN Min,XU Hao,ZU Maoheng,et al.CalliSpheres drug-loaded microspheres embolization versus iodized oil embolization for the treatment of hepatic metastases: a comparative study of short-term efficacy and safety[J].journal interventional radiology,2020,29(06):1253.
[9]何逸玮,邵国良.可视化栓塞微球的制备及研究进展[J].介入放射学杂志,2021,30(09):861.
 HE Yiwei,SHAO Guoliang..Preparation of radiopaque embolization microspheres and its research progress[J].journal interventional radiology,2021,30(06):861.
[10]彭 冉,李慕梓,刘宇洲,等.微球联合碘化油TACE治疗肝细胞癌的疗效和安全性[J].介入放射学杂志,2023,32(03):265.
 PENG Ran,LI Muzi,LIU Yuzhou,et al.The efficacy and safety of TACE by using microspheres plus iodized oil for hepatocellular carcinoma[J].journal interventional radiology,2023,32(06):265.

备注/Memo

备注/Memo:
(收稿日期:2016-09-29)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2017-06-13